Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: Single-center randomized controlled trial

I. Hsuan Huang; Pieter Sinonquel; Wout Verbeure; Chelsea Camps; Herman Devriese; Lieselot Holvoet; Bram Verstockt; Hilde Willekens; Hideki Mori; Raf Bisschops; Jan Tack

doi:10.1055/a-1664-8562

Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: Single-center randomized controlled trial

I. Hsuan Huang, Pieter Sinonquel, Wout Verbeure, Chelsea Camps, Herman Devriese, Lieselot Holvoet, Bram Verstockt, Hilde Willekens, Hideki Mori, Raf Bisschops, Jan Tack

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	81-83
Number of pages	3
Journal	Endoscopy
Volume	54
Issue number	1
DOIs	https://doi.org/10.1055/a-1664-8562
Publication status	Published - 2022 Jan 1
Externally published	Yes

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1055/a-1664-8562

Cite this

@article{e2131da3fdd44c3ea491be589a6c3c66,

title = "Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: Single-center randomized controlled trial",

author = "Huang, {I. Hsuan} and Pieter Sinonquel and Wout Verbeure and Chelsea Camps and Herman Devriese and Lieselot Holvoet and Bram Verstockt and Hilde Willekens and Hideki Mori and Raf Bisschops and Jan Tack",

note = "Funding Information: Jan Tack has given Scientific advice to Alfa-Wassermann, Allergan, Christian Hansen, Danone, Gr{\"u}nenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neutec, Novar-tis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsu-mura, Zealand and Zeria pharmaceuticals and has served on the Speaker bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyo-wa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion and Zeria. Bram Verstockt has received financial support for research from Pfizer; consultancy fees from Janssen, Guidepont and Sandoz; speakers fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion. Raf Bisschops has received speaker{\textquoteright}s or consultancy fees from Fujifilm, Pentax, Medtronic, Ipsen, Norgine, Cdx Diagnostics, Cook, Janssen; and research support from Pentax, Fujifilm, Medtronic and Cook. There is no support for this trial.",

year = "2022",

month = jan,

day = "1",

doi = "10.1055/a-1664-8562",

language = "English",

volume = "54",

pages = "81--83",

journal = "Endoscopy",

issn = "0013-726X",

publisher = "Georg Thieme Verlag",

number = "1",

}

TY - JOUR

T1 - Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread

T2 - Single-center randomized controlled trial

AU - Huang, I. Hsuan

AU - Sinonquel, Pieter

AU - Verbeure, Wout

AU - Camps, Chelsea

AU - Devriese, Herman

AU - Holvoet, Lieselot

AU - Verstockt, Bram

AU - Willekens, Hilde

AU - Mori, Hideki

AU - Bisschops, Raf

AU - Tack, Jan

N1 - Funding Information: Jan Tack has given Scientific advice to Alfa-Wassermann, Allergan, Christian Hansen, Danone, Grünenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neutec, Novar-tis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsu-mura, Zealand and Zeria pharmaceuticals and has served on the Speaker bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyo-wa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion and Zeria. Bram Verstockt has received financial support for research from Pfizer; consultancy fees from Janssen, Guidepont and Sandoz; speakers fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion. Raf Bisschops has received speaker’s or consultancy fees from Fujifilm, Pentax, Medtronic, Ipsen, Norgine, Cdx Diagnostics, Cook, Janssen; and research support from Pentax, Fujifilm, Medtronic and Cook. There is no support for this trial.

PY - 2022/1/1

Y1 - 2022/1/1

UR - http://www.scopus.com/inward/record.url?scp=85120060386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120060386&partnerID=8YFLogxK

U2 - 10.1055/a-1664-8562

DO - 10.1055/a-1664-8562

M3 - Article

C2 - 34820823

AN - SCOPUS:85120060386

VL - 54

SP - 81

EP - 83

JO - Endoscopy

JF - Endoscopy

SN - 0013-726X

IS - 1

ER -

Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: Single-center randomized controlled trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this